Episurf Medical AB (publ) (EPIS-B.ST)
SEK 0.12
(-0.82%)
SEK 0.12
(-0.82%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.36 SEK | -24.14% |
| 2022 | -0.29 SEK | 6.45% |
| 2021 | -0.31 SEK | 22.5% |
| 2020 | -0.40 SEK | 61.9% |
| 2019 | -1.05 SEK | 38.6% |
| 2018 | -1.71 SEK | -1.18% |
| 2017 | -1.69 SEK | 32.94% |
| 2016 | -2.52 SEK | -21.15% |
| 2015 | -2.08 SEK | -18.18% |
| 2014 | -1.76 SEK | -41.94% |
| 2013 | -1.24 SEK | -19.23% |
| 2012 | -1.04 SEK | -258.62% |
| 2011 | -0.29 SEK | 43.14% |
| 2010 | -0.51 SEK | -535.91% |
| 2009 | -0.08 SEK | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -0.06 SEK | 21.48% |
| 2024 Q3 | -0.02 SEK | 59.54% |
| 2024 Q1 | -0.08 SEK | 6.34% |
| 2023 Q3 | -0.08 SEK | 29.18% |
| 2023 FY | - SEK | -24.14% |
| 2023 Q2 | -0.11 SEK | -27.61% |
| 2023 Q4 | -0.08 SEK | -5.26% |
| 2023 Q1 | -0.09 SEK | 2.93% |
| 2022 Q2 | -0.07 SEK | -17.61% |
| 2022 FY | - SEK | 6.45% |
| 2022 Q1 | -0.06 SEK | 27.26% |
| 2022 Q4 | -0.09 SEK | -30.78% |
| 2022 Q3 | -0.07 SEK | 6.73% |
| 2021 Q3 | -0.07 SEK | 10.16% |
| 2021 FY | - SEK | 22.5% |
| 2021 Q2 | -0.08 SEK | -5.98% |
| 2021 Q4 | -0.09 SEK | -18.85% |
| 2021 Q1 | -0.08 SEK | 14.16% |
| 2020 FY | - SEK | 61.9% |
| 2020 Q3 | -0.08 SEK | 0.83% |
| 2020 Q4 | -0.09 SEK | -5.29% |
| 2020 Q2 | -0.08 SEK | 55.84% |
| 2020 Q1 | -0.19 SEK | 9.52% |
| 2019 FY | - SEK | 38.6% |
| 2019 Q1 | -0.35 SEK | 7.89% |
| 2019 Q2 | -0.42 SEK | -20.0% |
| 2019 Q3 | -0.19 SEK | 54.76% |
| 2019 Q4 | -0.21 SEK | -10.53% |
| 2018 Q4 | -0.38 SEK | 9.52% |
| 2018 FY | - SEK | -1.18% |
| 2018 Q2 | -0.45 SEK | -32.35% |
| 2018 Q3 | -0.42 SEK | 6.67% |
| 2018 Q1 | -0.34 SEK | 15.0% |
| 2017 Q3 | -0.34 SEK | -3.03% |
| 2017 Q2 | -0.33 SEK | 54.79% |
| 2017 Q4 | -0.40 SEK | -17.65% |
| 2017 Q1 | -0.73 SEK | -7.35% |
| 2017 FY | - SEK | 32.94% |
| 2016 Q4 | -0.68 SEK | -11.48% |
| 2016 Q3 | -0.61 SEK | 23.75% |
| 2016 Q1 | -0.57 SEK | -5.56% |
| 2016 Q2 | -0.80 SEK | -40.35% |
| 2016 FY | - SEK | -21.15% |
| 2015 Q3 | -0.54 SEK | 35.71% |
| 2015 Q1 | -0.56 SEK | -30.23% |
| 2015 Q4 | -0.54 SEK | 0.0% |
| 2015 FY | - SEK | -18.18% |
| 2015 Q2 | -0.84 SEK | -50.0% |
| 2014 Q3 | -0.54 SEK | -8.0% |
| 2014 FY | - SEK | -41.94% |
| 2014 Q2 | -0.50 SEK | -13.64% |
| 2014 Q1 | -0.44 SEK | -33.33% |
| 2014 Q4 | -0.43 SEK | 20.37% |
| 2013 Q1 | -0.35 SEK | 10.26% |
| 2013 Q2 | -0.38 SEK | -8.57% |
| 2013 FY | - SEK | -19.23% |
| 2013 Q4 | -0.33 SEK | -26.92% |
| 2013 Q3 | -0.26 SEK | 31.58% |
| 2012 Q1 | -0.24 SEK | -20.0% |
| 2012 Q2 | -0.23 SEK | 4.17% |
| 2012 Q3 | -0.18 SEK | 21.74% |
| 2012 Q4 | -0.39 SEK | -116.67% |
| 2012 FY | - SEK | -258.62% |
| 2011 Q4 | -0.20 SEK | -144.8% |
| 2011 FY | - SEK | 43.14% |
| 2011 Q2 | -0.83 SEK | -538.46% |
| 2011 Q1 | -0.13 SEK | 31.58% |
| 2011 Q3 | -0.08 SEK | 90.16% |
| 2010 FY | - SEK | -535.91% |
| 2010 Q2 | -0.08 SEK | -26.49% |
| 2010 Q4 | -0.19 SEK | 17.39% |
| 2010 Q1 | -0.07 SEK | 0.0% |
| 2010 Q3 | -0.23 SEK | -178.45% |
| 2009 FY | - SEK | 0.0% |